Manar Askar
@ManarAskar1
Followers
113
Following
98
Media
4
Statuses
51
Advanced Inflammatory Bowel Disease Fellow @MayoClinic , Former Gastroenterology Fellow @UniversityOfToronto
Rochester, MI
Joined October 2020
RT @JHaydek: 🚨AGA New Guideline Alert🚨 .🔗▶️AGA Living Guideline: Pharmacological Management of Moderate-Severe Ulce….
0
107
0
RT @LancetGastroHep: New research - D’Haens et al - Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multic….
0
25
0
RT @IBDGastroDocSg: Colorectal neoplasia surveillance intervals in IBD. - high-definition white light colonoscopy ✅.- good bowel preparati….
0
84
0
RT @EdwardLoftus2: Congratulations 🎊🎉🎈🍾 to @PriSantiagoMD and #ManarAskar on completing #IBD fellowship and looking forward to @SiriUrquhar….
0
3
0
RT @MayoClinicGIHep: 🎊 Congratulations to our 2024 Class of Graduating Fellows! 🎊 . Whatever is next in your journey, we wish you all the b….
0
10
0
RT @amjohnsonMD: The #REBOOTIBD group (minus a few) with our poster on RWE of risankizumab in Crohns @ManarAskar1 @P_DeepakIBDMD @ryanungar….
0
8
0
0
0
1
RT @waqqasafif: Induction and post-induction serum vedolizumab were not consistently associated with biochemical normalization. Proactive T….
0
10
0
Extensive Ulcerative Colitis and Exposure to Multiple Biologics precolectomy is associated with Endoscopic Cuffitis in IPAA patients. #IBD .@CrohnsColitisFn .@MayoClinicGIHep
0
0
2
I'm honored and excited to have our abstract get accepted at #DDW2024 meeting. All thanks to my mentor @amjohnsonMD for her unparalleled guidance and support!. @MayoClinicGIHep .@DDWMeeting .#GITwitter
2
1
34
RT @EdwardLoftus2: Diagnostic Performance of a Fecal Calprotectin Assay as a Biomarker for Mayo Endoscopic Subscore in Ulcerative Colitis h….
0
8
0
RT @amjohnsonMD: Excellent overview of JAK inhibitors by @EdwardLoftus2 #AIBD2023 .✅Highly effective even in bio-exposed .✅Rapid onset, man….
0
17
0
RT @amjohnsonMD: @NayantaraCoelho on management of dysplasia in IBD #AIBD .✅ random biopsies most helpful in PSC.✅ make the invisible (lesi….
0
5
0
RT @DCharabaty: #AHN23 @AHNGastro . Proctitis symptoms (urgency, tenesmus…) can really affect UC pt QOL @GKochharMD . #Etrasimod shows effi….
0
10
0
RT @Bealoquebea: Cardiovascular & VTE Risk With JAKi in Immune-Mediated Inflammatory Skin Diseases. 🔎35 RCT: >20k patients. ✅No difference….
0
15
0
RT @DCharabaty: #REMSWITCH IV->SQ IFX. No⬆️ #IBD relapse if IV 5-10mg/kg q6-8wks ↪️120mg SQ eow. ⬆️Relapse if.🔺IV 10mg/kg q4wks.🔺Baseline I….
0
32
0
RT @IBD_FloMD: 🌞🌞 Very pleasant memories of @MilestoneIBD retreat in Scottsdale. The ‘official’ group picture is now out 👇🏻👇🏿👇🏽 See you all….
0
7
0
RT @charlie_lees: Mesenchymal stem cells for perianal Crohn's disease?. Looks like they don't work after all. "Phase 3 ADMIRE-CD II study,….
0
21
0
RT @charlie_lees: SEQUENCE phase 3b RCT. Clear evidence of superiority for risankizumab over ustekinumab in Crohn’s disease. Endoscopic rem….
0
32
0
